ADVASAN MEDICAL GROUP AS: årsregnskap 2023 vs 2022
Grew 1418% on revenue, returned to profit
approved 2024-07-30; registry 2024-08-03; journal 2024 707181
Summary
What changed
Comparing Årsregnskap 2023 with 2022 for ADVASAN MEDICAL GROUP AS. Revenue 5 767 NOK → 87.5k NOK (+1417.9%). Net result -17.3k NOK → +22.2k NOK. Equity 39.9k NOK → 62.2k NOK.
On the constructive side: revenue rose; operating result improved; turned profitable.
Also worth watching: cogs moved. All figures are taken from the published annual accounts for ADVASAN MEDICAL GROUP AS.
At a glance
Scorecard
What improved
-
↑
Revenue rose
Operating income / revenue moved from 5 767 NOK to 87.5k NOK (+1417.9% YoY). Calculated
-
↑
Operating result improved
Operating result -17.3k NOK → +20.6k NOK (op. margin -300.1% → 23.5%). Calculated
-
↑
Turned profitable
Net result flipped from a loss of 17.3k NOK to a profit of 22.2k NOK. Calculated
-
↑
Equity strengthened
Book equity 39.9k NOK → 62.2k NOK (equity ratio 37.0% → 55.4%). Calculated
-
↑
Cash rose
Bank deposits 31.2k NOK → 84.0k NOK (+169.2% YoY). Calculated
Things to notice
-
·
COGS moved
COGS / varekostnad 8 594 NOK → 50.8k NOK (+490.9% YoY). Calculated